PortfoliosLab logoPortfoliosLab logo
Doximity, Inc. (DOCS)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US26622P1075
CUSIP
26622P107
IPO Date
Jun 24, 2021

Highlights

Market Cap
$4.64B
Enterprise Value
$4.59B
EPS (TTM)
$1.19
PE Ratio
19.50
PEG Ratio
0.12
Total Revenue (TTM)
$637.78M
Gross Profit (TTM)
$572.39M
EBITDA (TTM)
$268.45M
Year Range
$21.82 - $76.51
Target Price
$49.60
ROA (TTM)
20.69%
ROE (TTM)
24.45%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Doximity, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Doximity, Inc. (DOCS) has returned -47.38% so far this year and -59.85% over the past 12 months.


Doximity, Inc.

1D
-1.81%
1M
-5.01%
YTD
-47.38%
6M
-68.15%
1Y
-59.85%
3Y*
-10.39%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 24, 2021, DOCS's average daily return is +0.02%, while the average monthly return is -0.02%.

Historically, 43% of months were positive and 57% were negative. The best month was Aug 2021 with a return of +48.6%, while the worst month was Feb 2026 at -34.5%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, DOCS closed higher 50% of trading days. The best single day was Aug 9, 2024 with a return of +38.7%, while the worst single day was Aug 9, 2023 at -22.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-15.38%-34.53%-5.01%-47.38%
202510.69%19.29%-17.69%-1.98%-8.42%17.76%-4.22%15.64%7.67%-9.77%-22.06%-13.92%-17.06%
2024-3.89%4.75%-4.68%-9.74%14.16%0.87%0.11%31.36%18.46%-4.20%26.98%0.74%90.41%
20235.10%-4.65%-3.72%13.50%-16.54%10.92%5.03%-33.28%-10.99%-3.72%13.80%20.60%-16.45%
2022-9.10%34.63%-15.09%-23.46%-12.24%-0.49%21.54%-21.57%-8.95%-12.41%28.41%-1.27%-33.05%
20219.81%6.36%48.63%-12.28%-13.90%-2.63%-25.90%-5.42%

Benchmark Metrics

Doximity, Inc. has an annualized alpha of -9.58%, beta of 1.47, and R² of 0.13 versus S&P 500 Index. Calculated based on daily prices since June 25, 2021.

  • This stock participated in 176.33% of S&P 500 Index downside but only 88.41% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.13 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-9.58%
Beta
1.47
0.13
Upside Capture
88.41%
Downside Capture
176.33%

Return for Risk

Risk / Return Rank

DOCS ranks 3 for risk / return — in the bottom 3% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


DOCS Risk / Return Rank: 33
Overall Rank
DOCS Sharpe Ratio Rank: 22
Sharpe Ratio Rank
DOCS Sortino Ratio Rank: 22
Sortino Ratio Rank
DOCS Omega Ratio Rank: 22
Omega Ratio Rank
DOCS Calmar Ratio Rank: 88
Calmar Ratio Rank
DOCS Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Doximity, Inc. (DOCS) and compare them to a chosen benchmark (S&P 500 Index).


DOCSBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-1.22

0.90

-2.11

Sortino ratio

Return per unit of downside risk

-1.97

1.39

-3.36

Omega ratio

Gain probability vs. loss probability

0.74

1.21

-0.47

Calmar ratio

Return relative to maximum drawdown

-0.87

1.40

-2.27

Martin ratio

Return relative to average drawdown

-1.82

6.61

-8.43

Explore DOCS risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Doximity, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Doximity, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Doximity, Inc. was 80.53%, occurring on Sep 26, 2023. The portfolio has not yet recovered.

The current Doximity, Inc. drawdown is 77.16%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.53%Sep 13, 2021513Sep 26, 2023
-21.26%Jul 27, 20219Aug 6, 20213Aug 11, 202112
-19.76%Jun 29, 20215Jul 6, 202112Jul 22, 202117
-12.81%Aug 26, 20211Aug 26, 20215Sep 2, 20216
-7.11%Aug 17, 20213Aug 19, 20212Aug 23, 20215

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Doximity, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Doximity, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for DOCS, comparing it with other companies in the Health Information Services industry. Currently, DOCS has a P/E ratio of 19.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for DOCS compared to other companies in the Health Information Services industry. DOCS currently has a PEG ratio of 0.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for DOCS relative to other companies in the Health Information Services industry. Currently, DOCS has a P/S ratio of 7.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for DOCS in comparison with other companies in the Health Information Services industry. Currently, DOCS has a P/B value of 4.7. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items